Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887844-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	17.5	15.7	15.7	29.4	15.4	76.6	17.4	13.4	23.8	17.8	20.1	17.7	14.3	20.2	16.3	15.8	30.4	18.2	17.8	27.2	13.4	13.0	16.7	21.9	19.0	34.7	14.8	13.9	19.7	22.9	10.7	17.0	23.0	12.7	16.1	15.1	15.9	18.2	13.2	27.2	22.2	19.3	16.0	15.8	25.3	16.9	50.5	10.2	61.8	19.8	33.7	36.4	15.5	18.3	3.6	5.5	0.5	2.8	2.1	3.9	1.1	37.9	35.9	25.0	24.5	5.1	7.0	32.0	19.2	10.4	40.0	25.2	40.3	25.2	42.0	15.4	15.3	23.9	22.1	36.2	20.3	17.2	16.0	63.9	30.5	22.7	43.1	10.5	48.7	27.7	6.9	9.3	23.4	9.4	5.7	23.7	31.1	38.6	25.7	14.7	41.2	102.7	82.8	34.2	22.2	38.4	68.8	31.0	21.6	8.3	22.8	34.3	44.8	18.4	43.8	15.5	14.0	33.6	49.6	15.5	41.0	41.2	19.1	64.2	30.9	15.1	53.9	21.7	31.1	34.8	0.3	2.8	0.2	3.9	2.8	2.5	2.7	2.7	2.6	3.0	3.6	0.7	2.0	0.5	2.1	2.5	5.5	1.4	1.1	15.7	15.4	13.4	23.8	13.4	13.0	14.8	13.9	12.7	10.2	0.0	20.2	21.2	16.3	31.0	11.8	11.7	7.6	8.1	10.3	19.2	0.0	8.4	1.7	4.8	1.3	11.9	7.5	0.0	7.2	19.1	13.4	14.7	15.0	14.4	15.7	4.8	12.1	7.4	11.1	3.2	3.1	14.5	13.5	4.6	17.0	20.6	8.1	9.1	3.9	3.4	5.9	0.0	11.3	10.9	8.5	37.6	13.8	8.7	18.3	25.5
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		7900	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	33.4	31.3	31.8	31.1	39.8	21.9	35.4	54.5	45.0	33.3	33.0	32.3	26.7	32.1	39.0	26.1	36.9	30.2	25.4	21.5	33.0	30.1	38.4	51.4	26.4	37.3	31.5	37.4	31.7	35.4	41.9	31.6	32.0	40.3	32.1	36.8	19.9	32.8	33.2	38.3	31.9	39.0	37.3	40.0	38.0	31.1	24.5	31.5	52.3	40.9	26.8	42.1	32.4	29.5	24.8	24.2	19.4	25.2	45.4	31.7	30.8	26.7	29.3	38.6	23.1	26.9	26.7	25.7	26.8	29.2	38.3	36.7	20.6	11.8	32.5	20.9	28.6	27.5	33.2	46.3	31.1	52.6	37.3	42.5	29.5	17.2	17.8	23.6	48.8	27.7	21.6	32.1	19.0	33.9	23.1	31.7	20.1	47.9	28.5	25.6	16.5	40.5	19.8	66.7	33.2	27.6	43.2	39.4	24.9	27.6	31.6	29.9	19.6	32.1	27.7	24.7	29.6	33.9	22.4	27.5	32.5	24.3	43.6	43.5	23.5	33.8	51.1	27.6	28.7	19.4	19.4	18.4	19.4	27.7	25.2	31.7	24.8	27.7	28.7	24.2	23.0	28.5	29.6	4.0	45.4	24.3	15.5	23.5	30.8	31.8	39.8	54.5	45.0	33.0	30.1	31.5	37.4	40.3	31.5	14.9	23.5	17.8	14.2	38.9	22.5	13.7	28.1	18.7	31.8	19.2	9.8	25.7	26.6	19.6	6.8	24.8	19.3	23.3	16.9	25.3	25.1	20.5	31.2	42.2	23.0	27.0	23.1	21.5	34.8	4.5	17.3	23.9	30.4	32.5	28.0	20.3	21.8	14.4	19.1	29.1	16.2	6.5	24.7	25.5	23.0	45.4	32.5	28.7	28.8	15.5
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	25.5	22.8	18.2	25.5	22.4	45.5	25.5	39.0	26.0	25.6	23.2	24.6	23.2	20.1	25.2	21.8	28.0	21.5	24.1	19.1	18.7	11.6	19.9	19.7	31.5	25.0	23.1	13.5	32.6	26.2	33.8	36.1	29.0	19.4	21.9	22.1	27.6	24.0	34.5	24.7	26.0	27.6	19.4	19.2	32.9	20.9	34.1	24.4	46.1	26.4	19.6	30.3	27.3	30.5	5.1	8.6	20.1	9.0	12.6	3.6	1.7	20.4	20.9	27.0	22.5	15.7	16.0	27.2	14.3	19.6	20.2	14.9	24.5	24.9	30.3	21.1	16.6	17.3	17.8	31.9	18.8	18.7	19.5	17.1	34.3	12.8	12.4	17.4	19.8	25.9	14.1	19.5	17.5	25.6	22.9	20.2	12.5	36.4	36.7	11.6	13.1	16.4	13.2	24.6	14.0	15.9	13.9	20.0	20.6	14.6	20.2	18.3	15.2	23.9	25.1	13.2	31.5	27.6	18.1	27.8	10.3	20.4	13.3	10.0	20.5	19.2	28.2	9.8	14.3	15.3	6.5	5.1	3.7	3.6	4.5	3.0	4.3	2.8	2.7	1.8	5.1	2.4	2.1	20.1	12.6	9.0	8.6	2.5	1.7	18.2	22.4	39.0	26.0	18.7	11.6	23.1	13.5	19.4	24.4	62.5	60.7	48.0	38.2	45.2	69.5	21.4	25.5	20.1	27.3	24.4	129.6	38.6	6.6	27.8	52.5	40.9	47.2	0.0	25.1	27.9	32.9	50.8	40.6	25.1	20.9	30.2	42.9	52.2	50.1	51.1	56.1	40.8	37.1	57.7	40.9	27.3	28.7	38.6	54.1	9.6	68.6	84.1	49.5	82.5	133.9	54.1	80.0	43.6	29.6	49.2
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		190000	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	22.6	20.9	19.3	20.6	33.6	93.9	26.8	56.9	31.0	27.6	23.2	13.3	18.1	15.2	25.8	21.3	22.7	22.9	12.4	17.0	20.4	19.0	19.3	22.0	19.9	22.7	24.4	19.5	33.5	20.5	34.8	50.2	25.5	27.8	21.4	23.7	14.2	23.5	18.2	26.8	22.2	20.8	23.1	22.4	22.7	22.2	16.7	27.2	38.6	24.7	21.5	25.4	24.0	23.2	22.2	25.2	35.7	20.4	29.1	24.9	13.4	18.4	16.0	38.1	31.7	12.1	10.2	19.3	35.2	21.9	23.7	25.3	22.8	12.5	38.8	21.9	26.9	26.4	17.9	42.5	23.2	29.9	21.3	26.4	48.3	23.1	24.7	14.0	80.7	30.8	14.0	11.6	33.5	21.0	8.7	21.0	17.9	42.8	19.2	24.8	22.0	32.2	9.2	28.0	12.4	16.7	29.3	47.8	17.2	17.8	35.4	32.4	22.4	34.5	16.6	13.5	14.9	15.6	16.4	28.8	18.8	27.7	22.5	34.3	16.3	29.4	53.5	11.2	26.0	21.8	15.4	16.4	24.2	21.1	20.4	21.0	22.2	19.4	17.6	25.2	19.8	24.9	22.3	35.7	29.1	19.7	14.9	14.7	13.4	19.3	33.6	56.9	31.0	20.4	19.0	24.4	19.5	27.8	27.2	190.6	153.2	83.6	108.7	60.7	127.0	77.9	45.9	167.3	142.1	54.1	198.3	96.6	28.2	81.2	9.9	101.1	66.6	23.3	56.7	91.0	71.4	104.6	151.4	53.9	65.0	96.9	114.1	63.8	71.0	10.5	113.1	102.2	65.8	111.0	71.1	93.3	66.1	77.5	102.9	34.9	131.3	109.9	75.2	98.4	119.5	62.2	107.3	105.5	70.0	102.3
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968660-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	26.1	35.1	26.8	30.1	28.9	96.2	26.8	42.2	28.8	34.9	27.4	30.6	46.4	21.2	35.0	28.7	33.2	33.0	27.6	21.7	26.5	20.1	28.9	27.5	28.1	28.2	34.9	19.5	40.6	65.5	28.8	33.7	27.2	29.0	28.5	21.8	29.3	32.6	41.7	28.6	28.7	25.6	27.1	26.4	33.4	32.2	66.9	33.1	38.7	58.5	27.1	33.2	26.8	35.8	12.3	13.0	14.0	11.2	12.9	19.5	12.0	19.1	7.5	18.6	13.6	10.1	9.3	26.1	15.1	18.7	19.1	16.5	8.0	13.3	14.4	16.7	21.4	13.1	10.1	11.8	12.2	16.9	14.1	53.9	13.9	9.4	6.6	14.5	22.8	24.3	9.6	10.6	17.1	15.6	25.9	6.8	11.6	17.5	28.9	7.3	3.8	25.6	4.0	10.4	21.6	7.0	30.3	5.5	20.4	5.1	9.0	28.7	11.4	16.8	21.2	21.2	12.4	14.5	12.9	8.5	26.3	12.5	7.4	18.7	43.0	35.8	36.1	7.4	13.3	15.7	10.2	9.1	14.0	19.5	11.2	17.6	12.3	13.0	13.1	13.0	11.8	9.1	13.5	12.9	12.9	10.9	10.8	16.3	12.0	26.8	28.9	42.2	28.8	26.5	20.1	34.9	19.5	29.0	33.1	71.5	114.1	98.7	188.7	188.4	73.7	146.1	94.3	71.0	75.1	57.6	98.2	75.1	18.3	58.2	233.1	107.9	140.5	23.3	79.1	101.6	100.8	173.4	111.0	77.8	71.2	52.4	248.8	105.0	87.8	140.2	80.6	111.7	118.1	78.5	135.2	56.5	69.4	115.4	72.5	35.3	62.2	38.8	179.1	77.0	117.6	198.4	171.5	138.4	122.8	198.6
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	34.1	46.2	40.0	22.3	36.3	32.5	57.5	32.9	47.1	55.1	40.6	17.3	66.1	22.7	63.7	48.5	38.2	55.3	54.2	61.1	30.9	35.3	38.0	43.3	34.2	47.5	35.3	23.2	132.1	116.3	14.1	49.9	26.5	23.1	58.6	20.7	42.5	52.9	73.4	45.5	42.6	22.3	45.3	21.7	22.8	30.9	25.9	16.3	91.6	50.8	29.3	34.1	50.6	78.1	33.4	43.5	11.8	15.8	17.6	52.6	30.8	14.2	42.0	49.2	48.3	34.0	40.8	16.3	18.8	46.7	16.4	26.1	16.6	24.4	4.4	15.0	29.3	21.1	13.8	18.7	23.3	3.9	25.5	38.9	38.1	34.6	23.5	64.7	15.5	37.5	48.8	27.9	12.6	17.3	32.2	27.5	36.1	13.0	38.8	15.1	42.8	32.5	20.1	87.8	23.8	15.4	36.3	43.9	65.2	21.8	36.0	21.9	64.2	30.3	31.0	37.7	24.3	7.8	82.3	28.8	33.0	31.3	13.1	27.9	28.8	23.2	23.6	34.0	0.4	22.0	11.8	3.9	3.6	38.8	6.4	25.6	25.2	43.8	41.0	5.8	33.4	52.6	42.9	1.6	17.6	15.8	43.5	38.1	30.8	40.0	36.3	32.9	47.1	30.9	35.3	35.3	23.2	23.1	16.3	59.6	118.9	155.2	220.4	234.9	85.7	193.7	191.1	83.0	124.0	116.9	23.6	106.7	310.0	168.6	133.9	186.1	158.5	0.0	372.0	184.2	224.0	232.5	145.5	244.6	58.5	35.0	299.7	176.1	78.4	224.0	419.7	91.0	219.4	62.3	387.2	96.5	211.2	244.1	354.7	163.1	67.1	284.6	342.1	44.5	93.2	187.9	129.0	231.0	327.3	202.6
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350766-30355361	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	24.6	33.0	23.6	27.8	24.4	17.8	22.5	27.6	43.4	24.2	25.4	27.4	31.8	25.8	32.3	29.0	23.1	30.0	35.6	27.4	23.1	23.7	24.8	18.2	22.3	30.2	23.2	27.3	29.7	30.9	46.3	30.3	22.3	20.3	25.8	21.3	20.8	27.4	40.7	31.7	22.0	22.6	28.1	20.6	32.0	24.5	23.4	19.8	26.8	29.8	25.9	36.5	22.9	19.9	38.2	28.1	51.3	39.0	29.2	37.6	29.9	21.7	26.5	22.4	20.2	18.7	17.8	19.0	24.2	29.2	27.6	29.7	20.2	26.3	33.6	30.0	26.3	25.4	24.0	22.8	28.4	22.2	19.9	26.8	14.2	25.1	23.7	26.9	20.1	26.3	19.1	24.1	30.6	19.7	19.0	28.6	25.2	16.0	25.9	27.6	52.3	27.7	17.1	30.1	17.0	15.7	41.1	18.6	25.3	22.4	21.9	18.4	35.2	16.2	28.7	16.3	19.3	27.2	16.3	20.4	31.9	22.2	16.0	21.1	43.5	31.6	30.9	21.8	18.7	26.0	36.3	26.3	46.2	31.7	30.8	25.1	36.2	25.8	29.4	23.3	38.2	21.8	26.9	51.3	29.2	39.0	28.1	37.6	29.9	23.6	24.4	27.6	43.4	23.1	23.7	23.2	27.3	20.3	19.8	29.8	25.3	41.6	42.3	25.5	27.7	23.3	38.2	32.1	18.2	34.9	19.6	52.1	51.4	70.2	14.8	35.4	46.6	23.3	84.6	47.7	31.5	34.5	47.3	12.4	61.0	11.1	31.7	24.5	37.6	11.3	32.8	32.5	37.1	107.4	29.5	41.6	75.5	63.1	33.6	64.1	25.0	38.8	44.3	34.6	43.2	26.6	74.1	50.1	29.2	46.0
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.3	5.6	18.8	14.5	0.4	1.9	4.7	8.1	8.7	18.4	25.4	13.5	26.0	6.2	6.8	4.9	20.2	7.3	15.5	12.4	17.8	5.1	10.6	4.7	7.6	10.0	0.1	3.2	4.9	0.4	0.5	10.9	9.0	1.9	11.8	13.5	6.9	12.3	11.2	7.4	8.7	8.1	4.8	10.6	6.1	5.7	17.2	7.3	3.2	4.1	9.5	5.9	18.1	5.5	8.6	17.3	9.2	6.7	3.5	10.2	8.6	7.0	12.9	7.5	6.1	6.1	4.0	6.8	7.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	32.9	0.0	0.3	0.0	0.0	5.7	0.2	0.3	0.0	0.2	2.2	0.0	0.0	0.0	0.3	35.1	1.7	1.2	0.0	1.0	0.6	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	36.3	8.3	0.4	1.1	0.0	1.6	0.1
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.9	11.1	6.7	6.2	4.9	5.5	6.2	8.1	6.9	11.1	8.3	13.6	5.5	12.7	7.1	8.5	11.3	14.6	13.3	10.2	10.8	8.3	11.4	13.7	7.5	10.5	4.8	18.7	9.6	5.9	7.1	13.5	10.7	4.6	6.7	7.7	23.2	8.4	6.3	4.2	15.3	4.8	7.0	4.4	5.0	10.1	14.4	7.2	4.2	10.7	7.2	4.6	10.3	87.5	7.0	10.1	11.2	8.1	7.2	10.1	8.1	7.0	10.4	6.9	4.9	17.9	7.2	7.9	6.6	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3	23.8	26.1	37.7	45.0	57.5	45.4	12.1	35.7	29.4	40.9	36.6	60.9	27.7	11.6	24.4	15.9	29.6	32.0	23.3	23.8	24.7	35.7	62.9	27.8	38.9	23.9	33.4	29.9	27.6	37.0	14.0	34.5	34.5	25.3	27.9	26.9	31.5	36.1	31.6	31.8	12.9	67.7	32.3	33.0	113.1	90.5	60.3	48.7	42.9	28.8	77.9
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	22.1	26.5	34.6	33.0	41.1	42.5	32.8	40.6	51.0	25.1	22.7	29.1	29.7	23.4	29.9	30.0	28.5	30.0	22.1	35.3	32.3	24.9	26.0	29.9	32.3	33.6	42.6	32.8	34.6	37.9	31.9	29.2	31.0	32.3	27.0	26.5	20.8	25.0	30.5	83.6	31.5	25.4	29.1	47.1	37.7	25.9	35.0	39.8	34.5	32.8	30.6	33.3	21.6	33.1	29.2	34.8	43.0	28.2	20.5	31.9	27.4	26.4	23.4	39.8	24.1	17.3	12.7	31.6	18.7	17.4	26.8	23.2	26.0	26.9	30.0	28.5	17.5	17.6	24.5	38.2	27.4	17.8	35.0	35.2	23.6	35.7	21.5	21.6	36.1	29.7	14.8	31.8	25.8	36.9	22.4	21.4	33.0	28.9	23.2	20.0	33.6	38.7	36.6	46.2	38.7	29.3	24.1	24.3	33.1	26.0	36.7	24.2	28.1	20.0	29.1	31.3	27.6	31.1	50.1	18.3	18.1	26.8	22.7	30.2	32.5	27.1	34.8	19.0	29.6	21.0	43.0	28.0	25.2	31.7	28.2	31.5	29.2	31.2	30.7	34.8	27.4	31.9	28.4	19.8	20.5	25.5	26.8	31.8	27.4	34.6	41.1	40.6	51.0	32.3	24.9	42.6	32.8	32.3	39.8	29.8	31.2	60.7	103.3	55.9	38.3	63.7	43.3	24.1	34.2	50.6	31.4	78.2	43.1	53.9	18.8	54.0	43.4	46.7	56.5	101.7	51.2	66.2	45.1	36.6	60.9	41.3	57.8	47.3	40.7	12.7	41.4	41.9	33.7	72.1	44.9	42.0	50.7	48.0	39.6	37.8	49.7	19.4	59.0	110.0	97.7	54.0	107.6	44.9	46.5	107.5
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239537-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No		500000	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	22.3	26.4	29.4	28.1	32.6	52.0	23.1	49.1	32.2	24.8	20.7	24.3	21.3	21.8	27.4	34.5	27.1	23.2	17.0	21.8	24.3	16.4	20.0	19.7	21.6	36.1	23.6	26.8	42.2	23.5	28.6	36.4	21.0	24.9	21.5	21.5	22.2	25.6	21.4	25.4	23.3	23.1	22.3	20.7	24.7	21.9	22.1	25.8	42.8	25.5	10.5	32.9	21.3	24.2	22.0	25.5	21.0	21.5	19.3	30.2	12.4	28.7	24.2	35.8	25.1	13.9	15.9	27.0	19.0	22.7	27.1	25.7	25.2	19.8	45.9	19.6	19.2	15.1	27.2	35.1	22.4	29.0	29.9	23.9	37.0	25.0	28.8	20.8	49.9	27.1	19.0	17.8	21.8	9.0	18.2	20.8	27.7	38.0	49.3	22.4	33.5	46.7	32.7	34.6	24.0	20.7	47.5	28.4	32.1	21.3	34.3	30.2	26.6	25.5	23.9	25.9	22.4	28.7	35.4	23.9	20.5	25.1	19.3	31.0	31.7	25.6	57.4	16.6	29.3	26.3	21.0	17.1	18.7	19.7	21.5	20.9	22.0	22.0	20.2	25.5	19.0	17.0	20.1	5.2	19.3	17.8	18.3	30.2	12.4	29.4	32.6	49.1	32.2	24.3	16.4	23.6	26.8	24.9	25.8	11.9	19.8	32.8	39.9	67.5	52.9	29.0	22.9	21.4	25.0	17.4	35.3	55.0	31.5	46.3	14.2	31.0	20.8	0.0	49.2	71.9	38.1	25.5	34.6	18.7	34.7	84.2	50.4	17.2	27.8	13.5	52.6	28.0	23.6	55.9	26.2	35.0	48.6	21.0	49.8	20.2	42.9	38.8	30.4	71.1	72.7	51.7	42.8	35.2	31.1	46.0
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800434-38825481	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	6.0	4.4	5.1	5.5	5.8	29.7	4.6	6.6	6.2	5.5	4.8	4.4	5.4	5.4	6.0	3.6	3.9	3.1	4.5	3.0	4.3		4.6	4.8	4.6	6.5	5.0	3.7	5.0	4.3	4.0	7.8	7.5	4.4	5.1	4.1	4.4	4.5	6.3	7.6	8.6	5.6	4.3	6.5	5.2	4.0	10.4	5.8	7.8	4.6	4.4	6.4	5.4	5.6	4.5	4.8	18.0	5.2	3.4	4.4	2.5	5.9	7.4	5.3	7.4	6.5	5.3	4.6	6.2	4.8	8.8	6.7	6.2	6.2	8.0	4.5	5.9	5.9	13.6	5.9	4.7	9.5	7.0	8.3	5.6	7.5	6.5	6.4	13.8	9.1	5.5	7.5	7.1	6.2	7.6	5.4	8.6	8.7	8.1	5.7	3.9	14.3	14.5	4.7	5.0	4.5	10.5	7.2	6.3	7.7	6.0	5.1	4.7	6.1	4.1	7.4	7.6	6.3	11.0	5.8	6.1	5.3	7.9	10.0	7.3	5.8	10.3	6.6	7.4	6.0	7.6	5.2	5.8	3.9	3.0	3.3	4.2	3.6	3.7	3.6	4.5	4.4	3.3	18.0	3.4	4.1	4.8	3.1	2.5											53.6	65.8	41.0	55.5	56.7	36.2	16.5	20.4	42.8	40.9	22.7	78.5	31.2	24.9	23.9	91.6	38.3	59.9	0.0	20.6	29.6	30.9	43.3	57.7	21.2	25.2	25.4	40.1	33.7	24.5	18.9	34.5	34.1	25.3	34.3	24.6	32.1	24.1	42.1	32.5	21.6	45.5	38.8	31.1	88.3	31.3	67.0	66.1	52.2	22.8	57.6
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.3	13.5	6.6	13.7	11.8	7.8	3.5	3.9	10.1	9.1	4.1	4.0	3.1	11.8	16.9	14.1	5.6	15.3	26.0	9.6	2.7	40.9	5.5	4.8	9.7	4.5	7.5	6.1	18.2	15.6	10.2	32.1	18.0	6.3	18.0	24.1	2.5	8.4	2.1	6.6	27.4	5.7	6.0	2.9	5.6	6.0	3.7	20.4	4.0	6.2	17.2	6.9	3.1	4.0	13.2	2.3	6.5	3.5	1.3	4.9	1.3	9.0	10.3	12.8	25.3	0.8	10.5	5.4	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8	20.8	37.5	38.9	22.5	12.8	19.8	3.5	7.6	48.2	27.3	3.5	21.6	11.5	5.0	7.9	0.9	17.1	14.7	0.0	7.0	10.1	12.1	18.4	34.8	5.8	8.7	14.3	16.6	10.4	8.9	2.2	15.0	21.5	8.5	8.2	7.4	10.4	7.8	9.3	11.0	4.1	27.3	25.8	12.7	6.0	5.9	11.8	14.2	27.4	8.6	20.7
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	32.4	28.2	27.1	26.3	39.4	24.2	32.5	34.1	40.7	39.1	31.2	33.7	20.9	23.0	39.2	30.7	26.1	34.4	35.1	25.6	25.6	26.7	23.0	25.7	26.4	27.5	29.6	35.8	43.5	41.8	36.8	26.2	30.7	34.1	39.0	28.0	28.8	34.0	35.6	44.7	29.2	26.7	37.7	27.3	26.9	30.5	28.6	21.5	33.2	26.1	21.8	33.7	42.6	25.4	7.6	5.0	8.4	4.4	6.7	6.6	2.8	30.9	32.6	29.3	30.1	29.8	24.1	31.7	30.5	27.5	28.0	27.5	30.6	20.5	43.4	12.0	34.1	23.2	24.9	33.1	27.1	37.1	12.7	21.7	32.6	31.6	37.1	29.4	37.7	22.4	30.7	25.9	25.3	30.8	23.8	27.7	22.5	36.2	18.4	28.3	25.3	36.0	21.1	28.0	24.9	17.5	31.5	50.5	22.2	25.5	36.6	18.5	35.1	23.0	41.6	26.0	43.3	28.5	31.2	29.4	41.4	25.3	16.7	35.8	20.6	16.5	40.0	21.3	20.9	21.7	2.6	3.9	8.4	6.2	3.2	6.6	4.1	5.2	6.1	5.0	7.6	6.6	6.4	2.9	6.7	4.4	3.0	3.1	2.8	27.1	39.4	34.1	40.7	25.6	26.7	29.6	35.8	34.1	21.5	74.5	54.3	18.8	21.3	27.7	38.2	41.5	22.9	75.0	64.8	34.9	35.3	28.4	11.6	24.6	7.1	33.8	21.4	0.0	23.3	19.4	28.9	33.4	29.0	26.8	20.2	47.7	39.1	29.4	29.5	9.8	45.1	26.6	13.5	54.1	34.3	42.7	31.2	24.6	47.4	18.9	43.5	38.8	36.0	46.6	53.5	26.0	22.9	19.5	33.8	26.7
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		30000	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	30.1	29.6	49.1	24.3	24.2	23.6	29.3	35.2	31.0	37.2	37.0	30.0	36.7	55.5	21.7	28.8	43.4	25.3	63.1	42.4	58.0	20.3	29.9	48.1	32.4	24.2	14.2	49.5	33.2	19.7	25.5	36.2	24.5	23.9	31.0	26.2	45.0	22.4	42.1	22.8	64.9	33.2	53.4	30.2	26.9	42.8	57.6	25.9	44.3	43.5	42.2	26.4	27.3	26.3	24.7	36.8	28.8	25.7	28.3	31.6	20.8	23.8	41.0	17.0	28.6	66.4	21.1	40.5	37.5	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9	71.5	53.1	27.6	56.7	87.6	28.3	26.0	28.1	49.5	71.7	26.2	21.6	64.7	31.5	51.9	23.9	49.1	52.6	0.0	36.1	61.0	55.6	53.7	55.4	42.4	39.4	25.4	58.2	47.3	49.9	11.8	36.5	48.1	45.5	36.1	59.4	22.6	47.7	37.4	37.8	26.9	28.3	25.8	58.7	54.9	45.5	87.4	73.8	35.5	57.5	79.7
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716517-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	21.7	19.0	14.0	33.0	16.7	31.9	25.3	33.8	18.4	29.6	21.1	19.7	21.5	17.2	32.2	23.8	20.2	21.5	19.3	15.7	12.6	9.8	16.1	17.7	22.5	26.8	18.0	14.6	31.1	23.4	21.8	25.9	20.2	18.3	21.8	17.4	20.7	21.9	28.2	29.4	28.0	24.5	21.8	19.6	30.7	18.3	10.9	18.4	29.6	26.6	16.7	31.5	26.0	23.2	9.0	9.1	5.4	3.7	2.8	6.6	1.4	7.8	6.2	13.2	9.3	7.7	9.1	9.3	9.3	9.4	8.4	9.8	6.1	10.3	17.1	4.7	10.2	7.0	16.5	11.7	7.4	12.4	14.5	22.1	13.4	18.8	10.3	10.8	13.9	12.7	10.9	12.3	7.3	16.7	12.2	9.7	10.9	14.3	14.5	8.0	6.9	22.2	16.6	12.4	6.7	6.8	15.9	13.0	9.9	8.2	9.4	5.9	10.3	13.8	11.5	7.3	10.4	9.3	6.6	11.6	9.9	11.0	14.2	12.8	14.8	10.4	19.4	7.4	9.0	6.8	5.1	3.7	5.4	6.6	2.5	5.1	7.6	4.6	4.6	2.2	9.0	4.8	5.1	3.5	2.8	3.5	9.1	6.2	1.4	14.0	16.7	33.8	18.4	12.6	9.8	18.0	14.6	18.3	18.4	47.6	67.9	57.0	102.1	63.0	93.6	30.8	25.5	48.2	70.5	24.4	102.1	39.8	5.0	31.6	4.3	46.6	34.9	0.0	32.9	33.2	52.1	94.9	55.5	24.1	25.2	63.5	35.1	49.7	27.9	3.9	82.8	50.8	37.1	45.9	30.4	40.9	40.0	32.5	58.4	7.8	107.9	45.3	38.2	37.4	27.7	61.1	69.3	66.6	34.2	123.1
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202529	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 228.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	28.7	26.2	17.5	14.2	19.2	33.7	27.9	33.6	20.7	27.0	21.1	17.3	23.9	13.1	36.5	16.9	28.8	18.8	16.7	23.8	16.3	8.9	21.0	27.4	25.8	13.8	29.4	12.3	27.8	18.0	18.5	14.4	37.1	19.8	26.4	14.6	14.5	23.7	19.4	40.8	34.3	17.6	21.5	23.5	17.9	18.5	25.9	27.5	24.5	33.5	19.0	17.8	30.9	32.5	11.6	12.9	47.2	19.5	16.6	17.2	24.7	5.1	5.8	10.4	6.6	21.5	20.2	5.2	8.4	18.8	6.1	10.8	2.3	12.4	4.6	11.1	11.5	13.2	6.1	4.1	5.1	7.6	3.8	3.9	3.1	9.7	4.2	12.3	2.4	9.3	23.5	15.4	5.9	7.3	21.4	19.7	4.9	5.8	11.7	7.7	8.4	3.9	7.9	6.5	6.8	6.4	3.5	7.5	11.4	10.8	6.2	4.0	12.5	9.7	14.3	13.1	15.1	4.6	6.9	19.0	8.3	6.4	12.1	2.7	13.4	15.8	4.5	7.9	5.3	7.6	41.3	19.1	24.7	13.0	19.5	12.2	11.6	13.7	12.4	12.9	11.2	16.0	13.4	47.2	16.6	18.9	6.6	17.2	24.7	17.5	19.2	33.6	20.7	16.3	8.9	29.4	12.3	19.8	27.5	20.8	32.0	48.0	76.4	96.2	28.2	19.3	15.3	29.4	26.1	31.4	7.9	37.4	38.1	37.9	140.0	39.8	44.5	23.3	28.2	22.1	49.4	82.2	49.7	31.6	26.0	39.7	51.9	31.3	49.0	228.9	50.0	34.0	70.9	32.5	34.8	29.1	32.4	35.1	54.5	32.3	27.8	45.3	56.7	41.7	31.1	116.2	176.0	45.3	22.0	82.3
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662479	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Ciliated cells: 931.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA048798: AB_2680525"	"unprognostic (9.90e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	42.0	37.7	35.6	35.3	45.6	61.3	36.9	56.3	41.6	40.2	38.8	44.1	31.3	29.7	44.3	41.0	45.8	79.4	28.9	40.1	36.6	35.6	40.7	36.7	37.0	43.3	34.2	39.2	48.3	27.4	42.3	47.8	39.6	41.6	43.8	38.9	31.0	37.2	41.6	71.4	39.6	40.0	48.3	39.4	45.6	34.1	54.4	45.4	69.5	42.0	37.8	49.4	55.4	37.4	54.3	39.2	76.6	50.0	53.9	76.4	60.5	32.6	35.4	31.7	46.1	35.4	31.1	38.1	38.8	41.2	43.2	43.6	49.6	37.4	38.1	50.0	40.2	47.8	33.8	47.2	53.0	50.3	55.9	37.4	37.8	59.7	31.5	37.7	60.0	39.1	34.0	34.8	43.1	38.7	31.1	36.5	31.6	38.6	35.8	38.3	28.8	52.3	59.0	21.1	26.6	37.8	39.6	47.7	38.0	32.6	30.8	29.6	32.8	47.8	44.8	45.8	29.0	51.2	46.4	39.3	36.4	25.1	30.6	46.4	51.9	78.5	53.5	41.5	45.5	27.6	76.6	39.2	65.6	57.0	44.0	50.3	54.3	61.8	58.0	39.2	50.1	65.7	61.1	66.1	53.9	50.0	37.3	76.4	60.5	35.6	45.6	56.3	41.6	36.6	35.6	34.2	39.2	41.6	45.4	151.8	106.3	83.8	77.6	41.0	68.2	107.3	76.5	931.5	209.3	82.0	27.5	103.6	102.8	88.8	302.0	80.4	62.6	46.7	87.0	83.7	71.3	48.7	126.2	63.8	63.2	50.9	32.7	46.1	49.8	12.7	90.9	69.4	54.0	101.8	46.7	96.1	88.8	53.5	78.8	76.3	74.9	71.1	90.4	282.4	138.0	39.6	111.1	103.8	53.4	64.7
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161293	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	20.7	17.1	16.4	21.8	18.1	43.4	22.2	21.8	19.5	18.8	22.5	13.9	15.9	15.2	25.0	20.0	25.2	16.9	17.7	20.9	16.0	13.2	15.6	13.6	16.8	28.3	14.8	15.9	22.5	24.1	12.3	15.3	21.6	12.6	15.6	17.4	14.4	17.4	18.1	31.6	22.8	17.6	22.1	13.7	21.8	17.5	15.4	16.7	25.5	17.0	20.4	28.2	20.7	31.3	28.7	32.3	46.9	30.0	41.6	36.1	26.7	18.9	7.3	10.9	15.2	13.3	13.9	12.7	14.2	12.9	17.2	16.6	14.5	14.3	23.9	15.4	11.7	14.9	16.3	20.5	11.5	24.3	22.9	9.4	27.7	12.5	11.6	12.3	42.4	19.8	8.7	8.1	15.0	23.3	10.7	13.6	15.7	19.8	12.3	9.2	19.1	25.7	23.7	11.9	20.0	11.4	22.8	24.8	16.8	6.4	12.1	17.4	13.1	26.2	5.8	14.9	6.2	11.1	35.3	16.3	12.5	12.5	18.4	14.8	15.0	8.9	47.3	11.5	24.6	14.2	35.7	30.0	46.8	30.3	28.5	33.7	28.7	30.9	32.0	32.3	26.8	34.3	30.8	46.9	41.6	24.3	28.1	36.1	26.7	16.4	18.1	21.8	19.5	16.0	13.2	14.8	15.9	12.6	16.7	23.8	16.0	20.8	15.0	24.4	17.9	16.6	15.3	14.7	22.7	8.7	21.6	38.3	19.9	22.1	1.5	22.6	14.7	0.0	24.6	33.6	22.0	14.5	43.9	11.1	30.7	19.1	8.6	22.7	21.5	1.1	15.0	25.9	10.1	56.9	15.9	19.9	19.9	14.0	15.2	18.3	17.0	19.4	16.8	24.6	30.6	31.2	38.3	35.2	18.4	14.9
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	14.4	15.8	11.8	17.9	13.1	11.9	16.2	15.9	14.2	15.0	14.7	9.9	11.5	7.9	17.8	14.6	11.7	12.9	12.8	11.5	11.6	7.7	15.9	22.5	19.1	17.0	10.6	11.5	19.1	17.6	17.7	13.3	13.0	9.0	15.3	14.4	10.3	13.7	17.2	18.2	10.6	13.3	16.1	9.2	20.4	13.1	11.1	12.0	18.6	17.1	14.8	16.8	12.6	23.0	0.6	0.7	2.3	1.8	2.1	3.3	1.9	15.5	3.5	8.0	7.4	10.2	6.0	3.6	7.5	17.6	12.1	15.0	1.8	8.1	0.5	11.0	13.5	13.9	6.0	3.1	12.6	7.6	5.9	1.1	1.4	1.5	6.2	17.6	6.4	8.0	13.9	6.8	7.6	4.9	12.2	15.7	14.7	2.5	6.1	10.5	6.5	9.6	4.7	5.5	16.8	4.2	8.2	3.5	5.4	13.2	6.0	0.6	3.6	3.5	8.1	11.2	7.0	4.0	6.1	12.7	6.0	5.0	8.4	3.4	8.9	4.1	2.7	6.8	0.7	8.2	0.4	1.8	0.5	2.4	0.9	2.6	0.2	2.2	3.0	0.7	0.6	3.3	2.5	2.3	2.1	1.6	0.6	1.8	1.9	11.8	13.1	15.9	14.2	11.6	7.7	10.6	11.5	9.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719544-50756213	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	24.1	42.2	57.2	39.6	66.9	24.0	28.7	137.4	62.6	37.6	36.7	22.3	36.4	37.0	55.0	35.0	23.7	31.5	24.3	27.5	54.5	31.3	25.4	20.4	27.8	45.9	72.2	51.8	60.1	27.3	34.1	71.9	29.3	51.3	34.7	29.1	21.6	32.8	35.2	50.6	39.1	35.9	38.2	78.4	41.8	30.5	20.7	70.9	29.1	37.2	27.5	32.1	30.2	39.2	28.8	30.6	22.7	15.9	10.3	18.8	5.2	36.3	23.6	48.1	30.8	20.3	19.6	22.8	34.2	13.3	16.6	20.0	45.1	28.2	44.4	37.1	13.7	18.9	31.7	31.7	14.3	29.0	45.9	50.1	52.6	82.4	35.9	11.1	45.9	29.4	18.5	20.3	18.0	10.6	42.4	17.0	34.5	40.7	40.6	21.2	20.2	45.1	44.8	31.4	26.1	17.9	49.0	45.2	46.1	22.8	23.2	34.1	35.7	20.4	26.2	35.4	43.8	42.2	34.1	24.0	37.5	31.8	15.7	35.1	35.8	38.3	54.5	23.3	31.7	26.1	18.3	15.9	14.5	16.3	11.3	14.3	27.5	17.6	13.5	9.9	28.8	18.8	15.4	22.7	10.3	8.8	30.6	13.3	5.2	57.2	66.9	137.4	62.6	54.5	31.3	72.2	51.8	51.3	70.9	140.0	185.5	122.4	190.4	192.1	526.4	100.3	56.0	161.9	194.5	89.0	216.0	91.5	63.0	86.8	13.9	136.5	125.0	70.0	73.3	92.9	119.5	130.2	141.2	71.6	66.6	359.1	199.5	83.4	88.5	25.8	365.3	114.4	91.1	95.6	120.6	279.8	78.4	140.3	333.8	46.4	433.6	232.8	173.3	126.5	149.4	154.7	83.5	132.1	115.8	167.3
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Cell type enhanced"	"Detected in some"	15	"Intestinal endocrine cells: 5.2;Melanocytes: 1.7;monocytes: 4.6;Pancreatic endocrine cells: 2.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 35.1;RT4: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA			"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.7	1.1	0.0	1.7	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563622-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 63.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 20.0;HMC-1: 31.8;U-266/84: 14.8"									"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	8.0	63.0	0.0	0.0	0.0	0.0	0.0
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087454-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		12000000	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	52.7	57.6	34.4	49.7	36.7	79.5	149.6	33.3	39.9	38.8	47.2	32.4	45.7	41.1	54.1	39.3	55.6	39.3	45.4	55.1	34.0	31.2	41.6	69.5	46.3	77.8	43.5	29.8	42.3	88.3	42.8	30.5	52.7	37.5	36.3	31.2	29.6	47.9	42.0	149.0	41.5	39.6	59.7	39.1	52.0	43.2	31.6	42.1	91.0	43.8	59.9	48.4	49.6	148.0	15.1	29.2	49.6	32.1	31.6	30.3	28.9	61.0	63.1	54.6	42.6	58.9	45.2	88.0	45.9	42.5	45.6	38.3	73.1	41.2	84.2	23.7	52.1	49.3	54.8	64.0	66.8	46.8	60.0	49.4	67.2	38.7	111.6	66.5	55.6	64.8	39.3	43.7	37.5	52.4	34.2	57.8	22.8	68.8	62.4	57.1	76.0	71.6	83.6	55.1	58.1	41.8	58.0	59.8	84.3	61.9	63.3	51.9	41.8	37.7	77.4	54.2	40.3	46.0	50.6	53.0	42.8	53.8	36.2	57.8	83.1	85.3	85.4	45.3	77.3	52.6	12.6	30.8	45.5	30.3	32.1	27.8	15.1	23.7	26.0	29.2	14.4	24.2	26.9	49.6	31.6	26.7	21.0	27.7	28.9	34.4	36.7	33.3	39.9	34.0	31.2	43.5	29.8	37.5	42.1	142.9	126.1	207.0	259.8	429.9	61.2	0.3	191.1	77.6	87.6	186.7	21.6	344.0	230.5	178.2	24.5	194.4	308.0	280.4	172.1	388.1	237.1	214.9	113.0	353.2	342.4	55.6	171.4	230.2	473.7	20.0	172.3	379.2	285.1	245.3	179.1	119.4	191.5	189.4	175.3	361.9	37.4	168.1	288.4	83.0	70.6	477.1	588.2	233.9	170.9	314.6
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.9	19.6	25.4	27.1	30.1	26.1	21.4	30.8	37.8	42.2	34.5	23.1	21.2	26.1	15.8	36.6	27.8	17.7	33.1	41.2	46.9	26.3	16.5	31.4	15.6	22.3	30.8	31.2	26.4	28.0	38.3	49.8	39.2	25.4	36.1	28.9	32.0	33.6	36.6	17.1	23.9	14.9	19.2	19.1	21.4	23.8	13.2	15.8	29.2	15.4	14.8	16.7	18.8	20.3	29.4	25.1	19.5	21.9	23.2	25.2	28.6	22.2	27.4	17.6	22.8	32.9	23.7	15.1	33.5	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9	23.8	14.9	29.0	28.9	14.4	27.4	22.1	12.7	37.5	14.8	21.0	11.8	43.2	13.3	39.6	14.7	21.9	18.7	0.0	30.4	31.8	28.3	15.4	45.0	25.5	30.6	58.8	26.0	17.2	20.6	1.3	25.9	20.4	13.5	38.7	14.1	29.8	28.6	20.9	32.9	29.0	19.5	19.4	21.7	22.8	29.6	15.2	37.1	28.8	19.1	20.2
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 116.8;Late spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	17.7	24.5	25.8	22.9	31.6	43.8	25.3	30.9	33.2	28.4	23.2	36.2	23.4	19.2	31.3	27.8	28.1	41.4	28.8	20.6	25.9	19.2	24.4	19.7	25.1	24.4	38.0	24.9	71.5	24.1	27.7	24.4	30.8	27.4	27.5	22.5	24.0	28.1	27.0	23.8	28.5	21.2	27.2	24.5	26.9	28.0	28.2	38.3	37.9	33.5	17.4	33.2	21.2	27.0	22.2	33.0	22.7	28.5	20.9	26.8	27.0	17.4	17.9	40.4	18.8	18.3	21.0	25.9	20.1	17.1	31.1	23.2	20.9	12.1	29.6	13.0	23.8	14.7	20.3	42.0	23.0	24.3	14.2	31.0	23.5	21.0	21.6	17.0	36.5	24.1	14.6	26.3	22.8	23.8	26.0	21.8	22.5	25.1	19.7	24.4	19.5	30.4	26.5	22.3	22.9	16.9	38.7	36.8	20.0	25.8	11.3	13.3	11.4	24.4	21.3	21.5	24.8	19.6	26.9	19.8	19.7	23.9	13.3	20.2	19.2	23.4	27.5	16.0	22.7	27.7	18.1	28.5	22.7	25.7	26.5	26.8	22.2	23.0	21.8	33.0	22.2	25.6	22.5	16.6	20.9	22.7	16.9	23.7	27.0	25.8	31.6	30.9	33.2	25.9	19.2	38.0	24.9	27.4	38.3	17.9	13.7	27.3	20.7	17.4	29.4	10.4	15.3	14.7	13.6	19.2	19.6	31.6	18.3	25.3	116.8	15.7	18.8	23.3	21.6	31.9	16.3	27.2	24.2	15.3	20.0	23.8	18.4	16.0	20.8	271.9	20.1	18.4	18.6	49.5	13.5	17.7	21.5	17.5	23.3	15.1	14.4	45.3	20.2	20.9	35.0	15.4	43.6	25.4	16.9	19.7
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830778-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	18.0	14.5	28.6	15.5	37.0	23.2	19.4	23.1	29.7	18.9	16.0	18.2	12.0	13.3	24.0	15.6	19.6	19.4	14.6	16.2	23.4	17.7	13.9	14.8	17.6	28.6	24.6	25.7	24.6	18.5	14.2	18.9	17.4	24.4	15.3	18.0	11.7	15.1	19.5	17.8	17.8	15.1	21.8	24.6	16.9	14.3	21.4	25.6	20.7	17.9	9.4	24.6	18.6	16.0	11.9	9.7	17.0	11.4	14.0	16.5	14.9	21.1	15.0	32.7	21.2	20.6	21.6	18.8	22.8	24.0	39.1	31.7	16.8	24.4	30.3	16.1	25.9	15.2	19.1	38.4	21.3	28.4	25.4	23.4	39.5	20.4	24.7	20.8	36.3	28.1	18.8	23.3	35.4	31.7	17.6	23.1	26.0	33.4	20.7	23.2	13.8	39.6	21.4	40.4	18.7	17.5	32.5	27.1	28.8	21.0	19.5	22.9	20.9	28.0	21.9	27.0	17.5	19.2	22.9	19.0	19.3	17.6	30.2	21.1	19.2	29.3	38.3	18.8	47.4	24.6	17.0	10.0	9.1	14.0	10.0	16.5	11.6	11.6	15.8	9.7	11.9	12.8	12.1	5.9	14.0	11.4	7.3	11.4	14.9	28.6	37.0	23.1	29.7	23.4	17.7	24.6	25.7	24.4	25.6	14.9	7.7	28.1	17.4	15.3	22.6	11.5	7.6	18.7	20.5	5.2	2.0	41.6	26.6	24.8	26.4	14.6	12.6	0.0	22.4	34.1	19.0	13.0	25.4	15.8	23.1	7.9	11.1	20.3	14.3	18.7	22.2	16.9	10.1	40.5	14.5	19.8	24.7	16.1	15.9	19.9	13.9	25.8	16.4	27.9	40.2	12.3	36.7	24.5	15.3	17.4
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48897912-48903143	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	24.8	35.3	29.2	22.4	28.5	34.8	28.3	30.3	35.0	27.4	31.9	25.9	23.9	35.6	34.9	22.6	26.9	29.0	25.3	23.5	25.8	30.8	24.8	34.7	20.5	24.7	27.9	25.6	38.8	37.1	21.3	30.2	19.5	26.5	26.0	18.9	27.2	33.6	27.3	43.3	31.9	31.7	29.6	25.3	25.6	27.4	13.6	25.8	31.7	33.8	23.1	27.7	26.6	32.5	32.3	36.7	20.5	30.6	27.7	41.3	27.6	28.7	35.4	19.0	18.4	16.7	11.8	14.4	16.9	19.8	34.1	21.3	42.3	12.8	26.4	14.2	11.3	26.0	22.5	32.0	12.6	13.2	23.1	27.6	22.9	27.7	30.3	16.7	26.9	20.6	15.4	23.6	28.1	28.5	13.8	18.7	10.2	21.5	50.1	14.7	46.7	11.5	27.0	17.7	19.7	38.8	19.2	19.1	59.9	21.1	19.0	28.4	15.2	22.1	24.6	18.6	14.9	30.4	20.7	17.2	15.5	27.3	19.2	22.3	29.5	29.9	19.8	8.8	25.4	16.0	14.5	30.6	20.5	23.2	29.6	30.3	32.3	32.1	23.1	36.7	26.3	32.5	30.1	8.4	27.7	26.3	31.6	41.3	27.6	29.2	28.5	30.3	35.0	25.8	30.8	27.9	25.6	26.5	25.8	38.7	63.6	71.5	66.1	99.4	35.7	35.0	40.8	44.2	46.6	29.6	11.8	49.7	41.4	56.1	4.9	56.2	114.2	46.7	82.8	48.6	67.9	49.5	70.3	38.4	61.3	17.5	67.3	31.3	75.5	3.4	64.7	71.8	84.4	117.2	55.4	32.9	62.7	136.8	41.1	89.1	22.4	38.8	85.5	2.3	13.8	102.6	45.7	50.4	57.2	58.3
PRCC	RCCP1	ENSG00000143294	"Papillary renal cell carcinoma (translocation-associated)"	Q92733	1	156750610-156800817	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.3	24.9	28.5	25.8	29.7	33.7	23.7	33.2	43.5	29.8	30.0	35.9	21.8	24.6	35.1	22.8	30.3	25.6	28.7	23.8	28.0	24.5	26.1	33.1	22.0	30.1	22.1	25.2	30.1	23.7	31.0	22.7	38.8	22.6	25.6	21.5	25.6	37.2	24.0	47.4	33.6	30.1	25.7	20.4	29.7	24.1	26.2	19.2	51.9	27.5	29.8	30.7	25.4	23.8	21.4	27.1	36.9	23.1	19.3	22.1	16.9	20.1	17.4	13.8	15.8	11.6	9.2	24.0	14.1	13.8	15.7	13.6	27.3	17.0	20.7	24.4	11.1	9.1	21.0	19.6	14.8	12.3	25.8	25.6	15.1	12.9	17.6	14.3	20.8	17.9	13.0	17.2	13.7	12.5	12.3	14.4	13.7	24.9	19.3	11.0	35.9	23.7	24.4	33.3	28.1	21.7	20.8	12.2	27.8	16.5	19.4	24.5	43.8	14.9	37.6	23.3	23.7	27.0	33.5	13.2	16.0	16.8	17.6	23.1	49.7	74.3	32.0	15.8	13.5	14.8	26.9	20.0	36.9	20.5	20.6	19.6	18.0	18.5	22.1	22.4	21.4	18.4	18.9	19.3	19.3	23.1	27.1	18.5	16.9	28.5	29.7	33.2	43.5	28.0	24.5	22.1	25.2	22.6	19.2	8.9	16.0	27.9	32.9	46.5	17.3	10.6	20.4	12.0	15.9	19.2	21.6	54.4	18.3	35.7	5.8	27.0	25.1	0.0	28.1	52.6	29.2	25.0	16.2	15.3	37.9	27.0	33.0	23.4	18.7	7.1	28.1	25.4	20.3	51.3	23.1	16.5	29.8	27.4	26.9	23.7	16.8	32.3	32.5	33.6	48.1	44.8	84.6	34.1	27.7	31.8
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890730-60906588	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	20.5	32.2	33.6	27.0	37.9	32.0	28.9	49.6	61.8	30.4	30.6	21.3	24.5	24.2	27.1	21.4	36.7	34.9	20.1	18.0	32.8	46.3	21.5	39.4	18.0	33.1	35.0	50.0	41.3	31.3	45.7	37.6	24.9	46.2	37.7	31.5	21.5	28.8	30.9	31.9	39.0	24.6	28.8	23.7	28.3	23.7	15.2	24.4	46.3	25.3	24.4	41.7	24.8	24.8	3.1	5.3	4.4	11.8	2.4	3.3	1.2	43.7	34.2	38.4	27.4	22.6	19.8	34.9	23.8	32.4	47.9	36.0	37.5	33.0	63.4	32.1	22.8	28.7	40.1	54.0	42.9	37.3	43.2	34.5	52.7	27.1	40.3	32.7	69.6	37.6	21.0	32.7	36.8	41.5	14.0	37.1	38.9	52.3	36.7	23.4	61.6	70.3	52.4	67.9	34.5	46.1	62.5	39.3	49.6	24.2	28.7	32.8	39.5	29.5	49.1	39.7	18.3	51.3	38.6	23.2	21.2	34.2	36.9	38.4	32.8	45.9	63.8	26.4	47.8	31.9	4.4	11.8	2.6	3.2	5.4	2.6	1.3	2.6	2.3	4.8	3.1	3.3	3.0	0.7	2.4	2.9	5.3	2.2	1.2	33.6	37.9	49.6	61.8	32.8	46.3	35.0	50.0	46.2	24.4	17.9	21.3	32.2	30.9	37.4	31.5	14.9	17.8	18.7	26.1	26.2	9.8	75.0	23.2	33.3	15.9	20.3	20.2	23.3	44.7	70.4	22.6	29.5	22.0	40.0	40.5	58.8	37.5	16.5	27.1	2.7	34.2	21.5	25.3	47.7	32.9	24.1	30.9	24.6	36.4	22.4	22.1	45.3	22.3	18.4	35.8	36.4	34.0	23.8	47.8	26.8
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275343-113292905	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	16.4	20.9	13.8	23.8	17.4	18.4	21.7	19.4	23.2	15.2	15.7	14.4	20.0	13.4	18.9	28.6	22.9	17.8	17.6	16.8	15.3	13.9	21.5	24.3	15.2	19.6	12.4	19.2	24.3	22.7	19.1	19.6	17.2	19.0	20.6	17.6	13.9	16.8	19.7	26.1	21.8	14.7	21.1	14.4	18.7	15.9	16.6	12.6	21.8	16.5	18.2	23.1	18.0	24.6	16.5	19.9	18.1	21.7	17.0	17.9	13.7	12.8	22.0	14.7	16.1	10.4	10.7	14.9	20.1	10.1	22.2	16.4	21.4	12.0	26.7	11.9	10.9	22.9	29.6	30.7	17.7	25.1	18.9	11.5	13.6	19.2	15.7	9.5	23.8	12.5	7.7	12.1	23.2	22.5	8.3	10.6	15.0	23.2	14.9	18.9	20.0	22.3	17.1	23.3	33.6	24.3	20.8	35.2	18.4	9.7	10.5	19.3	13.1	29.5	16.0	9.3	12.4	24.9	12.4	10.4	18.1	13.7	23.3	25.6	19.1	51.7	26.3	14.0	15.4	23.2	18.1	15.8	15.1	15.2	19.3	17.9	16.5	15.2	13.8	19.9	16.4	15.5	15.3	5.3	17.0	21.7	13.1	13.6	13.7	13.8	17.4	19.4	23.2	15.3	13.9	12.4	19.2	19.0	12.6	8.9	17.3	24.5	12.9	14.0	20.0	12.5	7.6	18.7	18.2	17.4	17.7	21.3	21.6	13.9	13.3	9.0	4.7	0.0	14.7	27.7	14.9	9.8	18.5	8.1	16.2	27.0	16.8	6.2	10.2	10.2	10.6	17.5	5.0	31.5	12.7	22.1	12.2	10.5	10.3	13.2	22.1	0.0	15.6	28.3	21.0	16.4	18.0	11.4	12.0	12.5
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.7	9.3	21.9	22.8	16.8	17.6	23.8	14.4	13.3	13.2	14.3	10.3	14.4	24.7	10.9	12.2	15.1	17.2	23.5	12.5	21.9	13.5	18.2	21.3	26.7	29.3	13.1	28.2	12.7	15.2	17.5	17.2	20.3	14.9	18.9	21.7	26.7	22.6	15.2	18.3	22.7	25.5	25.2	12.0	8.8	31.4	22.3	21.7	12.7	15.9	17.6	15.4	20.3	18.2	25.5	25.5	14.2	25.1	16.3	16.4	12.1	14.1	15.4	20.1	20.0	31.2	13.2	18.8	13.5	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7	80.4	103.7	61.9	93.7	89.4	65.1	127.0	28.1	61.6	67.1	26.2	94.2	37.6	21.6	42.4	225.8	76.4	57.3	46.7	41.4	46.4	91.5	72.4	49.7	50.4	33.6	58.8	78.7	66.3	46.7	20.2	67.0	54.3	59.1	55.1	59.4	50.8	43.9	28.1	55.2	17.7	56.2	51.8	113.1	66.6	47.7	89.0	84.9	56.5	56.8	89.7
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47144869-47186813	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	18.1	22.2	19.8	38.0	21.9	34.0	17.1	41.2	22.9	19.9	20.5	25.7	22.7	21.8	22.1	17.3	23.7	26.2	29.1	21.7	19.8	18.3	18.4	21.6	17.1	27.2	20.1	19.2	36.4	27.4	20.1	28.3	24.9	17.9	23.5	14.2	18.5	25.1	28.8	20.6	23.8	23.7	18.9	17.2	24.7	20.5	8.7	21.4	32.9	26.8	18.0	22.7	17.6	20.9	15.9	14.6	14.4	19.2	12.3	18.3	11.5	20.9	22.7	21.8	25.8	11.7	9.6	25.3	16.0	9.4	16.5	16.1	19.8	17.2	25.6	9.8	11.0	21.1	20.5	28.4	20.1	9.1	26.0	25.7	19.1	27.6	20.7	17.1	19.3	23.1	12.6	9.7	27.3	22.2	11.9	17.7	24.8	15.9	20.6	10.0	32.0	35.4	32.8	35.9	15.8	25.5	31.3	18.2	26.4	12.2	18.6	25.9	19.7	24.1	18.1	15.3	13.5	22.2	19.3	15.4	19.5	24.8	21.0	16.7	21.7	17.5	21.1	17.3	14.0	27.2	14.0	10.8	14.4	18.3	14.5	17.0	15.9	14.7	15.3	12.3	15.6	14.8	14.1	10.1	12.3	19.2	14.6	16.6	11.5	19.8	21.9	41.2	21.9	19.8	18.3	20.1	19.2	17.9	21.4	38.7	44.1	14.3	20.3	9.8	26.5	30.9	25.5	30.8	36.4	8.7	13.7	27.7	10.0	17.2	0.6	18.8	24.8	0.0	15.2	23.9	18.1	14.5	23.1	19.8	16.9	20.6	34.3	14.7	12.9	1.6	16.7	11.8	15.1	18.0	24.9	14.0	16.8	18.6	24.1	11.5	25.3	0.0	16.9	5.7	6.1	9.3	38.6	17.5	23.4	16.5
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058436-73123898	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA		250000	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	29.1	25.3	24.2	49.2	36.9	66.0	31.3	48.9	36.4	29.1	25.9	26.4	34.2	24.6	33.7	37.7	27.1	32.4	29.7	22.3	28.2	22.3	21.6	23.5	28.6	38.9	26.5	35.4	36.3	35.6	32.7	45.1	28.1	33.5	26.1	26.5	24.1	29.3	40.5	35.4	29.0	28.9	30.3	30.0	30.4	27.6	29.4	29.7	34.6	33.8	28.4	34.3	26.3	29.4	21.5	24.7	17.4	17.0	23.2	18.4	9.0	32.9	19.1	30.8	23.4	13.8	16.3	27.0	27.2	19.1	21.1	23.4	25.5	21.3	39.8	14.4	18.6	16.1	25.1	35.4	16.4	36.5	24.9	18.6	33.5	15.1	19.5	8.7	29.4	21.3	11.7	11.8	24.7	20.3	18.2	21.0	14.7	34.3	16.7	22.9	24.6	38.2	17.2	26.1	20.3	21.1	33.0	33.6	19.5	17.4	23.1	20.8	19.8	34.1	22.7	12.0	19.4	32.5	12.9	26.5	31.3	30.6	16.7	27.1	17.8	31.5	49.8	14.0	21.0	21.4	11.2	14.8	13.5	18.4	17.0	17.3	18.6	14.5	15.4	15.5	21.5	15.4	16.1	17.4	23.2	13.7	24.7	15.9	9.0	24.2	36.9	48.9	36.4	28.2	22.3	26.5	35.4	33.5	29.7	214.4	331.5	163.2	170.4	201.9	245.3	123.1	86.6	165.9	260.5	87.2	253.3	130.8	14.9	80.3	47.9	128.9	92.3	46.7	106.8	156.4	139.0	166.8	234.1	80.0	100.2	170.0	148.9	90.2	100.2	18.9	146.2	140.8	77.6	124.4	93.3	156.4	103.0	89.7	129.4	32.3	258.3	71.1	142.8	189.6	180.1	206.9	155.0	146.0	97.8	216.1
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"SART1, U4/U6.U5 tri-snRNP-associated protein 1"	O43290	11	65961689-65979828	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	22.3	17.5	26.4	25.0	27.8	50.7	21.7	28.5	27.2	21.4	19.6	17.7	20.9	22.7	26.3	17.4	19.0	20.3	20.7	19.5	23.8	16.8	15.8	18.2	19.0	26.2	23.0	25.7	26.8	28.4	22.5	19.2	22.4	25.2	18.1	12.0	15.9	27.1	27.2	34.6	26.2	19.9	27.9	29.2	29.2	20.3	20.4	25.6	24.0	20.5	19.1	19.0	20.6	41.3	5.9	5.8	12.1	5.3	4.1	8.1	2.7	22.2	27.0	12.4	16.6	12.2	9.7	19.0	17.4	12.3	20.1	13.2	19.5	15.6	25.4	20.0	15.0	24.3	22.0	15.6	15.9	10.2	20.4	15.4	29.4	19.2	18.0	18.3	25.3	24.7	12.2	12.1	18.6	16.7	8.0	12.4	19.1	18.5	18.1	11.5	40.3	32.6	36.5	21.1	12.0	25.9	35.8	18.0	26.7	8.3	14.9	14.0	19.9	16.4	16.9	20.1	6.0	18.9	20.7	18.5	25.2	24.9	24.7	24.2	27.7	21.6	22.3	20.9	12.9	21.2	2.0	4.5	12.1	7.1	5.3	6.0	5.9	8.0	7.4	5.8	5.4	5.9	6.6	6.3	4.1	3.1	4.9	8.1	2.7	26.4	27.8	28.5	27.2	23.8	16.8	23.0	25.7	25.2	25.6	6.0	7.8	27.2	18.9	20.1	17.6	7.5	17.8	10.7	9.1	15.7	9.8	28.9	5.0	19.2	6.3	17.4	27.1	23.3	25.3	26.5	18.4	15.6	32.3	13.0	26.1	15.9	12.0	15.4	22.1	5.9	34.2	27.3	16.9	38.7	18.6	20.4	22.2	20.1	31.1	13.4	20.5	32.3	25.8	24.4	26.6	19.1	37.9	24.6	20.2	15.3
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.5	6.2	10.1	10.7	7.1	7.9	12.6	9.1	8.7	12.5	9.6	9.0	9.8	12.5	14.3	7.7	4.9	11.0	12.6	7.9	15.3	9.5	10.3	13.8	5.3	8.2	13.0	13.5	16.8	8.7	11.5	13.3	16.9	7.1	8.6	15.1	25.1	15.2	9.2	2.5	18.8	10.8	14.0	13.2	6.6	15.9	13.0	16.2	7.5	6.0	9.1	15.1	10.4	11.4	17.1	8.5	11.2	16.7	8.4	10.7	7.6	13.8	19.9	9.1	6.5	15.5	11.0	8.4	21.1	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4	26.8	23.5	17.7	14.0	38.7	5.2	7.3	2.5	13.4	25.0	8.7	0.0	7.6	13.3	5.8	47.5	16.2	11.3	23.3	6.1	8.4	15.4	11.4	34.6	17.9	9.7	14.3	16.7	12.9	16.1	12.7	9.2	13.9	18.6	5.4	10.7	11.4	8.2	10.7	6.0	9.0	7.7	6.5	17.3	15.1	13.9	51.7	11.9	15.0	9.8	16.6
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356947	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		19000	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	32.6	30.2	23.3	37.3	25.6	44.6	35.0	33.6	37.3	29.2	26.4	24.8	27.7	26.1	36.3	23.0	32.2	29.4	30.7	26.2	21.5	16.6	24.9	29.7	28.5	48.2	23.5	26.1	45.7	31.4	44.4	27.2	25.9	19.6	27.2	24.5	29.7	31.8	33.1	45.5	36.3	29.5	27.6	18.7	34.6	29.1	78.4	25.7	50.9	32.9	26.6	34.9	32.7	42.6	13.2	10.6	16.2	13.7	12.1	16.6	8.3	26.4	18.6	25.6	24.8	15.2	13.7	30.6	21.0	13.4	22.9	17.1	24.6	17.7	33.1	14.5	14.8	18.1	25.5	32.4	22.3	25.2	30.0	28.4	30.9	23.1	20.1	13.8	61.9	34.4	13.7	15.8	28.9	23.6	13.0	16.4	18.0	34.1	34.7	16.6	15.2	30.1	14.1	42.3	20.4	15.6	43.0	32.1	26.8	13.1	29.4	26.6	24.3	26.7	16.3	24.2	17.8	19.9	20.4	22.9	29.4	26.2	20.9	38.7	26.9	32.4	33.5	22.6	23.0	30.2	7.6	9.8	15.0	13.5	11.3	13.7	12.8	13.5	14.4	10.6	13.2	15.3	13.7	16.2	12.1	13.7	6.4	16.6	8.3	23.3	25.6	33.6	37.3	21.5	16.6	23.5	26.1	19.6	25.7	53.6	60.9	28.0	23.1	23.2	17.9	26.6	35.7	48.2	37.5	29.6	15.7	28.2	14.9	22.6	85.6	29.2	25.3	46.7	25.3	33.8	23.4	23.0	50.8	23.6	34.7	25.4	24.1	28.3	35.7	91.2	32.5	26.1	16.9	63.1	29.8	24.6	24.5	31.6	35.3	14.6	17.4	45.3	23.9	54.7	41.0	23.8	28.9	30.5	28.2	22.2
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197389784-197435091	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		840000	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	53.9	49.9	36.5	54.5	44.9	88.0	57.9	60.8	47.3	72.3	54.2	44.3	45.6	36.8	64.6	72.0	50.5	53.3	43.1	39.6	34.7	26.0	49.7	50.7	53.1	65.3	56.5	27.7	73.6	60.5	66.2	81.4	64.6	46.7	50.0	51.0	37.0	54.4	45.4	49.3	48.5	67.8	41.2	50.2	88.1	48.8	33.3	53.5	113.0	53.3	38.0	65.7	62.4	56.0	32.7	41.9	41.1	37.8	39.6	45.9	29.4	30.2	27.8	62.7	34.2	48.6	49.7	52.6	42.4	43.4	37.0	45.5	53.0	32.7	57.9	28.6	43.1	38.4	29.4	62.6	34.4	58.0	44.3	38.9	61.2	68.0	62.3	36.7	65.0	44.7	51.9	33.7	38.6	47.5	63.1	43.1	38.6	43.8	40.0	41.0	26.6	59.7	62.6	49.3	34.3	44.0	52.7	53.6	38.4	51.5	77.0	35.2	43.6	40.5	24.8	29.0	81.0	24.5	49.8	43.4	29.1	25.0	29.3	30.1	36.4	59.2	83.1	27.9	39.3	32.1	27.7	33.1	39.1	37.5	37.8	40.6	32.7	32.5	35.3	41.9	30.8	33.9	33.9	41.1	39.6	36.1	23.8	45.9	29.4	36.5	44.9	60.8	47.3	34.7	26.0	56.5	27.7	46.7	53.5	166.7	222.4	88.0	131.1	105.8	96.4	104.9	73.9	257.0	221.8	87.2	68.7	93.6	48.0	91.8	6.7	106.2	77.2	46.7	82.1	86.2	104.2	87.4	231.0	63.5	87.0	89.0	106.0	112.3	145.9	14.9	111.4	119.2	72.6	130.8	98.8	119.0	91.7	60.4	98.3	63.2	88.9	116.4	99.9	81.4	93.6	103.8	119.3	119.3	74.2	125.4
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		57000	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	52.4	42.9	50.1	45.8	61.7	75.7	47.3	57.0	75.7	50.6	46.0	61.7	33.0	42.6	53.0	61.8	45.4	65.0	43.5	47.3	51.2	45.5	51.2	56.8	45.2	55.5	54.8	42.4	74.1	60.5	75.2	63.5	58.9	50.5	50.1	49.1	48.8	42.4	51.4	48.8	50.0	46.8	51.9	44.6	56.7	44.2	86.0	52.9	85.9	60.6	34.5	67.7	47.7	47.1	43.8	39.7	63.3	57.8	43.2	57.9	51.5	53.0	42.8	46.3	43.4	48.1	44.4	38.3	40.4	55.0	63.1	47.5	35.0	46.3	50.8	45.8	47.5	63.1	49.3	66.9	46.4	53.0	40.5	34.5	54.7	40.3	57.1	48.7	54.2	41.7	37.8	45.3	63.7	73.8	42.8	45.2	45.2	51.1	84.4	48.0	72.0	61.1	79.9	48.0	40.0	40.0	55.6	39.8	72.0	47.7	43.9	37.0	54.0	40.4	42.7	59.9	35.2	53.8	34.3	37.5	51.9	44.2	57.7	45.5	64.8	75.9	64.5	57.4	35.8	46.8	56.9	39.4	63.3	57.9	46.0	55.7	43.1	51.3	54.0	39.7	43.8	50.3	49.6	52.0	43.2	57.8	30.9	50.0	51.5	50.1	61.7	57.0	75.7	51.2	45.5	54.8	42.4	50.5	52.9	119.1	114.9	136.2	123.3	98.9	85.3	61.3	107.0	198.1	111.5	62.8	84.4	166.5	77.9	136.8	194.5	90.9	93.8	70.0	187.3	151.3	122.2	90.7	114.7	66.0	109.4	101.7	79.2	66.9	93.2	48.0	111.4	109.6	62.4	232.6	79.8	113.3	135.0	91.2	122.4	73.9	100.8	77.6	120.5	169.9	151.2	86.6	156.1	138.4	94.9	111.1
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 455.4;Syncytiotrophoblasts: 484.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.8	2.2	1.0	12.6	26.3	16.5	13.5	1.9	1.7	2.1	1.9	13.0	8.1	0.4	1.1	2.0	12.2	0.0	0.5	0.1	31.4	1.4	51.2	0.1	1.1	13.2	12.6	16.2	21.0	6.6	27.6	0.3	4.0	32.0	5.9	0.1	0.1	0.4	0.8	3.2	1.3	0.4	1.5	0.2	78.5	0.2	0.3	3.1	39.6	0.1	50.9	7.6	0.1	0.3	61.1	4.8	2.1	29.5	2.7	6.0	56.0	6.5	4.5	1.9	6.5	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1	35.7	233.2	40.3	98.2	162.8	10.8	19.4	96.8	24.1	99.0	64.6	33.4	39.9	18.3	60.3	7.2	107.9	230.9	0.0	151.5	27.8	58.7	45.7	257.3	17.5	283.4	0.0	10.2	455.4	148.5	5.6	14.1	322.4	254.8	6.4	46.9	4.3	52.7	129.6	14.9	92.1	28.6	12.9	39.1	48.4	7.5	101.6	484.9	9.6	6.4	68.4
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.8	14.0	36.4	20.5	32.2	29.1	26.2	19.5	26.1	20.7	19.6	23.3	20.2	45.3	11.4	32.5	23.9	20.7	42.2	32.6	33.0	18.7	20.7	58.7	19.2	30.9	23.9	55.2	27.0	30.8	38.0	24.5	37.6	26.5	31.4	24.7	44.2	45.7	29.7	28.1	29.5	31.1	39.7	30.5	16.3	29.0	38.8	33.4	32.0	24.9	20.9	20.6	32.7	28.0	22.6	31.5	25.5	32.5	31.2	22.2	20.7	16.6	21.2	42.9	35.1	54.1	23.8	47.4	21.6	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4	381.2	269.8	245.0	287.1	384.7	382.2	339.3	303.2	329.2	315.1	286.1	208.1	195.6	164.2	182.7	62.5	272.4	180.8	256.9	180.4	138.6	293.6	211.2	400.4	301.9	149.2	430.6	179.2	276.8	201.3	39.3	364.7	259.5	207.5	184.0	159.3	365.4	155.4	161.4	369.9	137.2	353.2	375.1	318.2	436.1	320.9	344.7	273.6	278.4	160.2	183.4
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	11.1	13.4	12.8	15.6	14.5	38.0	16.3	24.2	14.7	12.9	10.1	8.9	17.3	10.9	18.5	15.9	9.6	13.6	10.6	8.2	12.4	13.3	10.6	10.5	12.5	12.7	11.1	12.0	12.2	14.3	23.4	30.3	12.2	11.4	12.2	10.7	11.9	12.4	16.5	11.9	20.2	12.6	13.7	11.3	14.9	11.0	11.0	11.4	19.5	14.3	9.8	9.5	10.6	10.5	6.5	6.0	8.5	5.6	7.7	6.0	2.8	5.1	6.3	8.9	5.3	4.2	7.9	8.8	6.0	3.5	3.3	3.5	9.3	6.0	7.7	7.7	4.6	4.4	6.9	4.5	6.0	5.8	5.4	10.2	7.3	16.2	6.8	3.7	6.6	8.6	4.6	6.0	4.0	4.5	6.9	5.2	4.5	6.6	5.6	3.5	5.0	6.9	15.5	4.7	2.1	3.2	9.3	4.1	5.5	5.7	9.3	10.5	7.1	5.7	2.7	4.9	6.9	6.8	8.6	5.5	5.3	3.2	7.2	6.1	6.0	4.1	8.7	5.2	10.7	5.7	8.5	5.6	5.2	5.0	3.9	5.4	6.2	4.7	6.0	4.2	6.5	5.6	5.6	4.1	7.7	3.7	6.0	4.4	2.8	12.8	14.5	24.2	13.8	12.4	13.3	11.1	12.0	11.4	11.4	86.4	149.8	64.8	77.1	58.6	59.7	64.9	66.2	132.5	117.2	43.6	110.0	73.9	31.5	45.7	31.9	85.0	41.6	70.0	48.3	73.9	67.2	73.1	94.7	57.6	44.0	63.5	74.7	58.3	48.5	44.8	77.3	55.5	40.5	37.9	43.9	86.7	44.4	37.0	72.2	27.8	96.5	45.3	63.8	65.4	57.5	60.6	100.9	61.0	47.2	68.6
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		12000	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	17.2	13.9	27.6	24.7	15.6	16.1	27.1	20.2	13.4	20.3	23.3	15.3	29.0	38.6	12.8	17.1	13.5	21.7	27.5	19.8	26.7	13.2	19.1	29.6	27.0	18.1	10.9	34.1	19.7	10.9	12.5	16.4	24.2	23.2	17.5	19.0	28.7	21.2	20.8	14.9	30.9	22.9	45.4	14.1	9.5	27.6	22.1	18.8	17.7	18.0	16.8	15.2	21.8	17.7	15.0	21.7	15.9	16.7	19.4	17.8	18.5	24.1	20.2	19.0	14.5	47.7	19.2	40.1	19.7	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8	145.9	144.9	171.3	231.9	268.6	176.0	131.8	137.6	180.7	174.0	115.1	111.9	129.0	169.1	144.9	235.5	146.8	116.3	163.5	128.5	137.4	157.1	230.0	229.3	203.4	133.1	117.6	113.6	127.1	162.6	96.6	155.3	180.0	146.8	260.5	126.0	204.1	128.5	135.3	141.8	117.6	174.7	135.8	173.5	224.9	222.2	258.2	201.7	198.3	147.2	308.0
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752329-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	41.4	50.2	50.1	73.1	69.8	105.5	48.0	85.3	77.1	53.1	51.7	61.5	57.9	56.1	60.4	44.5	53.1	56.8	60.7	43.7	51.0	28.2	47.2	56.0	48.7	53.3	70.3	38.2	70.8	74.8	88.1	49.1	43.8	48.8	52.5	48.2	45.6	80.8	63.0	91.7	67.4	63.4	46.7	52.9	63.2	61.7	37.8	69.8	48.7	58.9	38.3	46.2	52.0	69.5	9.0	11.6	36.4	8.9	23.9	4.7	0.9	23.1	29.6	47.2	32.5	33.3	32.5	27.9	26.3	14.9	23.6	21.0	24.5	26.9	41.2	20.2	29.1	19.9	33.3	37.6	33.4	25.0	29.9	39.0	35.4	55.1	42.3	15.1	37.0	51.3	33.2	32.4	34.5	41.0	47.0	24.2	29.9	39.6	40.7	21.6	41.2	34.8	59.5	44.3	16.9	16.4	61.3	19.1	32.0	30.3	24.8	31.1	27.5	34.9	35.8	20.4	34.3	32.5	30.4	34.3	33.4	34.3	21.7	32.9	36.1	27.5	89.9	11.6	26.8	22.4	36.4	8.9	4.3	3.2	3.9	3.0	5.2	4.0	3.0	2.0	9.0	3.5	4.7	18.3	23.9	3.5	11.6	2.0	0.9	50.1	69.8	85.3	77.1	51.0	28.2	70.3	38.2	48.8	69.8	131.0	223.1	135.5	295.8	275.8	386.9	120.6	137.6	99.0	127.4	158.7	274.9	154.0	56.3	132.6	66.3	179.8	178.8	70.0	155.2	172.0	158.0	296.9	129.6	159.6	137.3	414.7	182.0	132.6	96.7	50.6	233.0	154.4	114.7	165.1	168.0	254.6	138.2	149.0	180.7	81.9	356.7	194.1	177.2	214.7	238.6	319.2	231.0	133.1	160.7	304.5
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell type enriched"	"Detected in some"	220	"Cardiomyocytes: 650.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0.0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0.0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0.0	0.7	0.2	5.9	0.3	0.0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	1.4	1.3	1.4	650.0	0.0	1.4	1.2	0.0	2.0	0.1	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.9	0.7	1.1	0.2	0.2	0.0	0.0	0.0	0.3	1.0	0.9	0.8	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.3	0.0	0.5	0.7	0.6	0.4	0.0	0.7	0.0	0.9
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399741-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Enhanced	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	12.2	14.9	18.3	13.6	20.8	13.6	12.5	24.7	28.1	16.9	16.2	32.0	10.9	16.9	18.8	10.7	13.6	17.9	19.2	18.9	17.9	15.7	12.4	14.8	13.7	15.8	22.7	18.8	26.7	19.5	16.3	12.5	13.8	15.9	16.9	9.1	19.6	21.6	19.1	27.8	17.3	15.7	14.3	17.2	17.2	14.4	11.9	20.6	13.0	13.3	10.9	13.0	16.8	14.3	5.9	8.2	6.1	8.7	5.2	7.6	6.3	12.0	12.5	12.7	14.5	13.5	11.5	11.3	10.1	12.6	15.5	14.7	11.5	8.7	18.2	8.0	9.8	8.6	14.7	12.9	14.8	6.2	14.1	20.6	8.0	15.3	11.3	11.8	15.0	15.4	11.5	13.2	11.7	12.8	11.8	11.3	11.1	14.5	12.5	7.7	7.8	11.5	12.5	8.9	19.0	12.8	20.8	18.2	18.1	11.9	12.9	11.3	8.4	14.3	17.8	12.5	8.3	14.5	16.5	9.6	10.8	17.3	8.3	8.2	19.8	12.7	13.2	12.8	10.6	10.5	1.4	8.7	6.1	7.6	7.2	6.2	5.9	4.6	6.1	8.2	5.9	7.5	6.7	1.3	5.2	6.7	3.8	4.6	6.3	18.3	20.8	24.7	28.1	17.9	15.7	22.7	18.8	15.9	20.6	3.0	4.1	4.9	2.8	1.8	52.3	6.5	5.1	2.7	3.4	3.5	17.7	10.3	0.0	5.2	1.3	4.5	4.2	0.0	3.4	7.1	4.7	2.4	4.7	4.2	6.1	27.0	10.9	3.1	5.6	2.4	7.2	3.9	5.0	8.2	4.5	11.8	4.8	4.3	8.5	4.2	18.2	6.5	4.7	7.1	8.9	2.9	4.7	8.2	5.6	1.3
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	11.9	9.1	11.8	12.5	14.5	10.7	7.7	19.0	12.5	10.5	10.7	12.3	10.9	10.4	15.5	8.1	13.4	8.2	7.7	8.5	10.9	9.9	11.6	16.5	7.1	17.6	18.1	7.6	9.9	8.1	11.1	23.3	9.6	11.5	8.4	8.7	8.9	10.4	7.6	12.1	9.1	9.4	10.8	14.2	12.8	9.6	26.3	17.7	16.2	9.2	7.8	17.8	14.6	7.8	11.7	11.0	9.1	9.7	9.7	14.2	6.4	12.7	6.9	16.1	13.5	10.2	7.4	20.0	7.0	7.0	15.3	16.0	14.2	8.3	18.2	5.9	9.8	23.0	8.4	20.8	11.7	18.9	5.8	9.0	11.0	9.1	9.5	8.1	25.0	10.2	4.9	7.2	16.3	10.6	6.6	16.3	16.0	24.9	8.7	13.2	9.6	18.2	14.2	15.9	16.5	10.2	25.6	15.5	16.6	8.4	12.5	10.9	8.2	19.7	10.2	11.7	19.2	6.9	17.8	8.2	13.7	14.7	10.9	23.2	7.1	12.2	26.7	11.6	17.3	11.7	9.1	6.7	5.7	9.5	9.7	14.2	11.7	11.6	12.0	11.0	9.5	13.6	13.3	0.7	9.7	7.8	6.5	11.4	6.4	11.8	14.5	19.0	12.5	10.9	9.9	18.1	7.6	11.5	17.7	17.9	9.4	6.2	13.1	11.4	30.6	7.8	2.5	9.4	18.2	10.4	19.6	20.5	13.3	14.2	47.4	13.4	4.5	0.0	7.0	13.3	10.4	10.2	26.5	10.5	13.7	27.0	9.1	7.4	6.3	5.6	17.8	13.1	3.3	10.8	7.1	13.8	10.7	8.7	15.9	6.8	25.5	6.5	11.3	57.7	26.8	8.0	15.7	17.9	13.2	10.8
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224416-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		22000	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	33.9	30.5	19.8	27.2	28.5	26.8	27.0	30.7	33.7	25.5	26.6	28.4	24.8	20.2	30.2	23.6	29.7	25.1	21.5	28.1	19.7	20.2	25.2	37.1	24.6	32.4	21.2	20.1	29.6	24.8	38.6	32.6	35.6	28.5	32.1	24.1	26.3	27.4	23.7	79.1	27.0	29.3	27.6	20.7	32.6	26.5	23.8	22.2	57.4	29.0	28.6	38.8	27.4	26.1	36.2	23.1	49.3	24.0	25.2	29.8	22.2	31.3	20.3	35.0	29.8	28.0	22.8	29.3	33.8	34.1	34.1	35.2	23.8	28.9	58.5	12.8	34.8	24.1	29.1	39.0	32.8	42.7	30.1	21.9	48.5	31.4	25.1	30.5	49.2	32.7	34.9	20.7	34.6	29.4	23.5	37.4	35.5	40.1	30.4	24.4	17.8	52.9	27.3	41.4	19.5	16.0	50.7	41.5	31.2	24.4	44.5	22.2	26.5	38.6	25.0	28.0	35.4	23.1	21.1	39.4	28.4	33.0	26.4	35.4	18.2	32.0	53.2	26.7	33.7	29.5	36.6	20.1	36.7	29.8	24.0	25.2	32.2	25.3	26.0	22.7	36.2	26.8	23.3	49.3	25.2	23.8	23.1	21.3	22.2	19.8	28.5	30.7	33.7	19.7	20.2	21.2	20.1	28.5	22.2	107.2	81.4	114.8	82.1	50.5	89.2	98.7	56.0	99.0	85.3	45.4	29.5	126.9	82.9	123.3	5.3	83.5	50.1	46.7	91.4	130.0	82.0	97.4	88.1	63.2	88.9	82.6	69.5	65.1	67.8	7.8	74.2	78.2	69.2	174.1	63.3	132.3	90.9	52.6	78.5	58.7	85.1	90.5	82.4	132.9	116.0	59.8	120.5	106.5	79.1	64.3
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787415-62790405	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	26.1	34.6	13.2	19.5	15.7	13.4	36.0	6.3	15.4	24.9	31.3	23.7	37.7	24.5	27.8	53.6	24.9	28.9	35.0	21.8	12.9	11.1	43.1	55.4	39.0	43.2	17.1	9.8	27.4	47.1	15.5	17.5	39.8	20.9	28.8	29.3	28.0	55.1	54.2	16.7	29.7	44.2	20.4	19.9	30.4	26.5	29.4	14.8	25.5	44.9	21.2	28.2	24.1	24.0	35.5	80.6	70.4	67.6	28.3	35.4	53.5	12.6	25.8	6.4	12.7	50.4	12.8	7.9	13.9	17.1	11.0	12.6	14.7	29.4	5.8	19.9	27.4	15.9	23.2	11.8	12.5	8.5	17.2	16.8	8.4	11.7	13.4	34.0	10.6	11.8	24.6	20.3	20.7	25.6	21.9	11.0	17.3	11.6	16.6	12.4	28.8	13.6	20.6	9.6	26.6	28.5	9.3	10.3	30.2	20.5	15.6	8.8	9.7	17.9	23.2	23.7	13.4	27.1	13.1	14.2	14.4	10.8	26.4	11.4	19.0	11.2	7.5	20.8	6.5	16.7	52.6	67.6	70.4	35.4	64.9	34.8	35.5	32.5	33.9	43.2	31.5	28.9	28.5	49.9	28.3	61.8	80.6	31.3	53.5	13.2	15.7	6.3	15.4	12.9	11.1	17.1	9.8	20.9	14.8	56.6	43.3	42.5	61.1	61.0	12.3	1.1	63.7	73.6	54.6	57.6	0.0	154.6	31.5	119.9	4.5	76.8	91.9	23.3	131.2	131.6	80.8	88.4	54.2	69.2	120.1	7.9	62.6	65.1	70.8	7.8	70.2	79.2	101.3	101.0	82.1	70.3	107.6	133.3	43.2	73.2	12.7	64.7	35.0	93.4	90.3	66.5	154.8	55.4	88.9	75.9
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674715	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	32.1	39.3	40.0	51.9	40.0	68.2	34.1	53.4	44.1	39.6	43.7	41.2	37.0	46.2	45.0	32.5	47.9	43.6	35.4	33.8	35.0	29.4	36.5	39.1	35.6	59.6	41.1	33.7	51.4	38.3	37.7	48.1	42.9	31.5	36.8	29.7	35.9	36.4	39.5	33.3	42.7	43.0	34.7	32.4	58.1	37.4	104.4	41.4	68.4	42.0	34.0	50.4	36.3	42.9	3.0	4.1	5.5	4.0	1.4	3.0	1.7	44.2	72.7	44.5	36.5	21.1	21.4	48.0	35.9	33.8	61.8	60.2	42.2	42.2	53.6	29.2	30.4	30.6	36.3	55.2	50.0	27.5	40.3	92.3	44.9	32.5	38.7	34.3	51.0	51.5	29.1	30.3	46.1	30.5	23.2	35.5	36.3	53.5	34.6	31.2	41.6	70.8	44.9	49.0	38.3	57.9	77.3	28.7	42.8	33.9	51.9	52.9	41.1	39.4	37.3	22.7	26.0	36.4	54.0	30.3	54.4	39.5	25.0	75.8	31.5	42.6	63.6	24.2	50.6	46.2	0.2	2.6	2.2	3.0	4.0	2.6	2.1	2.7	2.4	2.4	3.0	2.2	2.0	5.5	1.4	2.6	4.1	2.9	1.7	40.0	40.0	53.4	44.1	35.0	29.4	41.1	33.7	31.5	41.4	3.0	7.8	30.2	34.6	40.3	39.4	2.0	28.1	2.7	10.3	26.2	29.5	50.4	16.6	27.1	3.6	25.3	37.1	0.0	20.6	50.3	29.4	26.5	34.5	24.6	32.5	33.4	43.7	25.2	23.2	5.2	41.1	28.1	18.6	39.7	38.5	23.8	24.5	21.0	32.2	19.6	49.8	0.0	31.7	23.3	28.8	34.4	60.1	33.7	38.2	39.4
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal keratinocytes: 372.2;Suprabasal keratinocytes: 398.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	37.6	31.0	21.5	38.7	24.7	106.0	37.5	30.1	22.3	29.7	28.2	19.4	25.1	19.1	33.8	34.6	30.3	28.8	27.3	28.9	22.0	22.1	28.5	28.8	29.7	36.1	20.9	21.2	37.1	30.1	23.1	31.2	35.0	22.1	33.0	28.7	23.7	30.3	27.2	81.2	29.3	28.6	30.9	22.6	36.5	27.1	20.4	21.6	53.2	36.3	26.2	39.3	33.4	34.6	26.6	22.3	33.4	27.1	23.9	30.5	14.7	13.8	13.3	30.0	27.4	35.2	39.0	19.6	21.7	73.7	27.8	37.2	25.7	13.2	34.4	13.1	23.8	61.2	18.9	29.1	25.4	36.2	17.9	19.5	34.3	14.5	36.2	29.5	31.0	20.8	46.3	24.7	31.0	41.1	21.3	21.1	33.8	36.8	32.3	29.3	13.9	42.7	41.7	25.4	21.6	11.2	28.5	19.4	24.6	29.9	17.1	28.7	20.9	40.8	23.2	10.7	21.2	10.7	38.5	18.8	19.7	21.4	28.5	31.5	23.4	26.0	53.0	18.1	31.1	19.6	27.2	19.2	22.6	23.4	24.3	26.4	26.6	28.3	27.8	22.3	23.8	25.6	25.8	33.4	23.9	27.1	18.9	30.5	14.7	21.5	24.7	30.1	22.3	22.0	22.1	20.9	21.2	22.1	21.6	32.8	59.0	84.2	176.7	372.2	29.5	46.6	84.1	36.1	35.2	57.6	33.4	93.4	72.9	99.7	34.1	64.1	45.2	46.7	70.5	105.3	82.6	229.3	39.3	81.8	67.3	35.0	59.1	50.3	77.6	39.5	60.4	106.3	231.2	127.2	57.7	39.0	73.8	54.5	47.7	75.7	31.8	71.1	169.7	61.3	74.5	398.0	124.8	111.7	56.9	130.8
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562909-88627596	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 961.1;Late spermatids: 410.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli, Nucleoli rim"	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	13.5	12.6	16.2	10.8	16.4	9.7	13.3	23.4	19.6	14.0	15.3	14.3	17.5	10.6	17.2	15.5	12.4	15.8	10.4	12.3	14.8	8.4	15.2	24.9	13.9	9.1	16.1	16.3	17.1	19.4	19.3	24.1	14.8	16.0	14.9	16.6	11.3	18.0	16.3	15.4	13.6	15.2	14.8	11.2	9.4	12.7	73.1	14.1	9.3	19.4	8.2	11.4	16.2	12.8	13.3	17.4	21.7	21.1	18.5	17.7	13.3	16.4	31.8	29.2	23.1	23.2	22.5	29.6	25.3	23.0	36.0	31.8	22.6	26.0	23.0	18.3	25.7	19.8	20.3	20.6	23.6	49.1	19.4	15.5	11.2	22.7	18.4	23.3	24.6	14.7	18.0	27.8	28.1	28.2	24.6	23.4	21.1	21.9	10.6	32.5	35.1	22.2	13.6	18.6	25.9	28.1	19.4	37.3	10.0	24.3	29.7	21.9	19.6	31.6	36.2	17.7	25.2	33.0	16.1	17.2	43.8	26.8	18.4	25.1	13.6	11.8	25.7	21.5	12.0	20.0	12.9	16.0	21.7	15.9	20.0	17.7	13.3	15.5	17.5	17.4	12.0	14.7	14.7	2.9	18.5	21.1	9.5	13.2	13.3	16.2	16.4	23.4	19.6	14.8	8.4	16.1	16.3	16.0	14.1	113.2	41.2	16.2	22.0	20.1	59.3	19.0	25.5	75.0	46.6	19.2	72.6	40.8	29.9	22.1	961.1	18.2	22.3	0.0	19.9	23.4	21.3	22.4	43.9	29.7	17.6	62.0	30.5	23.4	10.4	410.4	36.5	14.0	5.0	13.6	27.9	35.0	19.9	14.0	44.6	24.5	76.1	12.9	27.6	125.8	76.6	17.2	34.0	17.5	29.2	13.6
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570381-88631966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	17.5	13.5	15.5	28.1	19.0	30.9	15.3	28.3	21.4	15.1	17.1	20.7	17.4	20.3	20.5	12.2	16.5	15.5	21.8	13.9	15.6	12.6	11.5	13.6	14.7	23.1	17.1	10.5	18.2	19.7	18.8	17.7	18.7	15.0	13.2	11.8	13.4	18.4	13.0	27.6	16.3	20.2	14.6	14.3	22.4	16.9	31.4	18.4	27.0	15.3	10.7	18.6	17.2	21.3	4.5	5.8	7.6	9.9	6.4	6.8	4.1	15.4	20.8	15.2	15.2	7.5	6.5	24.5	15.6	8.5	14.6	6.7	20.4	13.5	19.0	13.3	7.3	9.8	18.6	14.3	11.8	9.3	11.1	18.1	12.6	10.3	17.3	9.6	9.7	11.0	5.9	9.0	15.5	7.5	6.1	9.0	13.3	34.2	6.3	7.2	29.9	30.9	17.2	23.8	12.1	12.6	38.1	10.5	13.9	6.6	9.9	16.1	13.9	29.9	8.3	8.7	9.3	18.9	13.2	12.2	15.8	16.4	11.4	15.7	14.2	22.3	45.5	14.0	22.7	16.6	4.5	4.5	4.3	6.0	5.2	6.7	4.4	5.5	6.1	4.0	4.5	5.0	3.9	7.6	6.4	9.9	5.8	6.8	4.1	15.5	19.0	28.3	21.4	15.6	12.6	17.1	10.5	15.0	18.4	26.8	21.6	22.5	15.2	14.9	26.0	8.4	17.8	14.7	33.0	15.7	33.4	19.5	6.6	13.7	54.6	14.7	19.7	46.7	14.3	18.3	11.6	15.0	19.7	12.9	15.7	27.0	24.0	15.4	18.7	5.8	20.1	22.5	13.5	22.6	16.2	24.7	14.3	20.1	15.9	6.3	42.6	6.5	12.7	30.5	34.6	19.4	21.1	30.5	19.3	14.2
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567065-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 114.7;Suprabasal keratinocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 50.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051857	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051857: AB_2681641"	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	9.9	3.0	3.6	9.3	2.9	10.9	15.0	2.2	3.1	7.6	6.7	3.1	6.1	4.5	6.2	2.9	10.0	5.7	5.7	5.4	3.4	1.6	6.3	10.3	8.8	20.9	3.0	2.3	6.1	7.1	8.3	3.9	65.5	4.8	7.1	6.8	5.7	11.0	8.6	5.2	11.9	8.9	6.6	3.4	16.8	6.7	9.9	2.4	16.7	6.9	4.9	9.5	10.6	8.6	4.3	4.1	19.4	11.5	5.8	3.6	2.2	9.2	11.0	9.3	13.5	8.7	10.0	20.4	10.4	10.7	11.8	5.9	7.1	10.4	9.0	11.2	12.6	15.3	9.1	7.4	10.9	13.7	6.4	2.1	2.9	4.8	12.3	6.8	4.6	12.5	5.4	10.6	6.3	17.6	9.3	6.7	9.4	6.3	42.8	8.8	36.9	16.0	10.3	9.8	5.3	11.0	12.6	7.8	10.4	6.8	20.7	0.9	2.6	9.6	50.0	10.1	12.3	14.9	19.8	4.7	23.9	8.9	12.2	12.7	17.8	19.7	7.6	8.7	5.3	7.6	5.9	4.9	8.4	2.8	6.3	3.6	4.3	3.0	3.5	3.9	3.9	3.4	3.3	19.4	5.8	11.5	4.1	2.9	2.2	3.6	2.9	2.2	3.1	3.4	1.6	3.0	2.3	4.8	2.4	0.0	10.1	12.3	36.1	114.7	0.6	7.5	15.3	22.7	14.8	17.4	0.0	11.9	8.3	23.0	36.2	14.6	32.6	23.3	14.3	14.2	18.3	61.3	11.5	24.3	13.3	0.0	5.8	16.0	38.2	20.0	6.4	34.4	20.3	6.4	27.1	2.0	19.8	28.1	4.9	9.6	0.5	0.0	8.6	5.4	24.0	93.3	37.8	20.8	21.0	72.7
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	12.3	11.3	14.6	10.6	27.1	11.6	16.6	20.4	17.3	14.2	11.1	26.2	15.5	9.6	16.4	18.3	9.1	10.9	11.3	9.3	17.3	14.1	11.8	10.0	12.5	11.1	26.7	12.1	14.1	15.0	18.4	15.6	10.6	17.6	13.3	11.4	12.1	12.6	14.8	10.5	16.2	10.4	15.9	22.7	11.6	11.2	8.6	24.7	4.8	13.9	8.1	11.5	10.4	10.6	7.4	4.3	5.5	3.4	4.9	4.8	1.8	9.2	4.9	13.0	12.8	9.5	14.1	7.0	9.6	11.8	12.7	12.2	10.4	5.0	3.7	7.2	12.9	8.6	3.1	12.4	7.1	14.9	13.0	13.7	12.4	18.4	9.6	15.1	11.7	12.1	11.2	16.3	12.8	20.7	14.1	9.9	4.5	12.7	10.9	10.5	5.0	2.9	13.7	7.6	3.3	10.1	1.3	8.4	3.9	6.7	11.2	4.3	11.4	9.0	7.2	11.4	13.5	10.9	9.7	12.2	21.4	10.6	10.1	13.8	16.5	15.4	7.9	10.1	8.7	13.2	5.5	3.0	2.5	3.9	3.4	2.7	6.1	3.8	4.8	2.4	7.4	4.4	3.9	4.4	4.9	1.9	4.3	3.1	1.8	14.6	27.1	20.4	17.3	17.3	14.1	26.7	12.1	17.6	24.7	8.9	10.5	7.5	4.2	1.3	12.5	10.1	10.2	4.0	11.4	10.4	11.8	4.5	5.0	6.0	6.0	8.7	5.0	0.0	4.9	2.9	5.1	4.9	3.5	4.0	3.3	14.3	9.8	5.5	6.7	5.7	6.9	4.4	3.3	10.0	5.6	9.4	5.5	3.5	11.3	2.9	15.0	0.0	4.9	9.4	7.0	1.6	4.6	5.7	5.8	4.2